|
1
|
Ganesh K and Massagué J: Targeting
metastatic cancer. Nat Med. 27:34–44. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Smyth EC, Nilsson M, Grabsch HI, van
Grieken NC and Lordick F: Gastric cancer. Lancet. 396:635–648.
2020. View Article : Google Scholar
|
|
3
|
Guan WL, He Y and Xu RH: Gastric cancer
treatment: Recent progress and future perspectives. J Hematol
Oncol. 16:572023. View Article : Google Scholar
|
|
4
|
Lachaud C, Moreno A, Marchesi F, Toth R,
Blow JJ and Rouse J: Ubiquitinated Fancd2 recruits Fan1 to stalled
replication forks to prevent genome instability. Science.
351:846–849. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nalepa G and Clapp DW: Fanconi anaemia and
cancer: An intricate relationship. Nat Rev Cancer. 18:168–185.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Du F, Peng L, Wang Q, Dong K, Pei W, Zhuo
H, Xu T, Jing C, Li L and Zhang J: CCDC12 promotes tumor
development and invasion through the Snail pathway in colon
adenocarcinoma. Cell Death Dis. 13:1872022. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ajani JA, D'Amico TA, Bentrem DJ, Chao J,
Cooke D, Corvera C, Das P, Enzinger PC, Enzler T, Fanta P, et al:
Gastric cancer, version 2.2022, NCCN clinical practice guidelines
in oncology. J Natl Compr Canc Netw. 20:167–192. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Oh SC, Sohn BH, Cheong JH, Kim SB, Lee JE,
Park KC, Lee SH, Park JL, Park YY, Lee HS, et al: Clinical and
genomic landscape of gastric cancer with a mesenchymal phenotype.
Nat Commun. 9:17772018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stillman B: Smart machines at the DNA
replication fork. Cell. 78:725–728. 1994. View Article : Google Scholar
|
|
10
|
Li GM: Mechanisms and functions of DNA
mismatch repair. Cell Res. 18:85–98. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kraemer KH, Patronas NJ, Schiffmann R,
Brooks BP, Tamura D and DiGiovanna JJ: Xeroderma pigmentosum,
trichothiodystrophy and Cockayne syndrome: A complex
genotype-phenotype relationship. Neuroscience. 145:1388–1396. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Saldivar JS, Wu X, Follen M and Gershenson
D: Nucleotide excision repair pathway review I: Implications in
ovarian cancer and platinum sensitivity. Gynecol Oncol. 107 (Suppl
1):S56–S71. 2007. View Article : Google Scholar
|
|
13
|
Turczynski S, Titeux M, Pironon N and
Hovnanian A: Antisense-mediated exon skipping to reframe
transcripts. Methods Mol Biol. 867:221–238. 2012. View Article : Google Scholar
|
|
14
|
Badra Fajardo N, Taraviras S and Lygerou
Z: Fanconi anemia proteins and genome fragility: unraveling
replication defects for cancer therapy. Trends Cancer. 8:467–481.
2022. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hsieh CC, Hsu SH, Lin CY, Liaw HJ, Li TW,
Jiang KY, Chiang NJ, Chen SH, Lin BW, Chen PC, et al: CHK2
activation contributes to the development of oxaliplatin resistance
in colorectal cancer. Br J Cancer. 127:1615–1628. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Webster ALH, Sanders MA, Patel K, Dietrich
R, Noonan RJ, Lach FP, White RR, Goldfarb A, Hadi K, Edwards MM, et
al: Genomic signature of Fanconi anaemia DNA repair pathway
deficiency in cancer. Nature. 612:495–502. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Fagerholm R, Sprott K, Heikkinen T,
Bartkova J, Heikkilä P, Aittomäki K, Bartek J, Weaver D, Blomqvist
C and Nevanlinna H: Overabundant FANCD2, alone and combined with
NQO1, is a sensitive marker of adverse prognosis in breast cancer.
Ann Oncol. 24:2780–2785. 2013. View Article : Google Scholar
|
|
18
|
Titeux M, Turczynski S, Pironon N and
Hovnanian A: Antisense-mediated splice modulation to reframe
transcripts. Methods Mol Biol. 1828:531–552. 2018. View Article : Google Scholar
|
|
19
|
Steeland S, Timmermans S, Van Ryckeghem S,
Hulpiau P, Saeys Y, Van Montagu M, Vandenbroucke RE and Libert C:
Efficient analysis of mouse genome sequences reveal many nonsense
variants. Proc Natl Acad Sci USA. 113:5670–5675. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Litchfield K, Reading JL, Lim EL, Xu H,
Liu P, Al-Bakir M, Wong YNS, Rowan A, Funt SA, Merghoub T, et al:
Escape from nonsense-mediated decay associates with anti-tumor
immunogenicity. Nat Commun. 11:38002020. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lemonidis K, Arkinson C, Rennie ML and
Walden H: Mechanism, specificity, and function of FANCD2-FANCI
ubiquitination and deubiquitination. FEBS J. 289:4811–4829. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang J, Dewar JM, Budzowska M, Motnenko
A, Cohn MA and Walter JC: DNA interstrand cross-link repair
requires replication-fork convergence. Nat Struct Mol Biol.
22:242–247. 2015. View Article : Google Scholar
|
|
23
|
Lu Z, Mao W, Yang H, Santiago-O'Farrill
JM, Rask PJ, Mondal J, Chen H, Ivan C, Liu X, Liu CG and Xi Y: SIK2
inhibition enhances PARP inhibitor activity synergistically in
ovarian and triple-negative breast cancers. J Clin Invest.
132:e1464712022. View Article : Google Scholar
|
|
24
|
Liu TX, Howlett NG, Deng M, Langenau DM,
Hsu K, Rhodes J, Kanki JP, D'Andrea AD and Look AT: Knockdown of
zebrafish Fancd2 causes developmental abnormalities via
p53-dependent apoptosis. Dev Cell. 5:903–914. 2003. View Article : Google Scholar
|
|
25
|
Sun S, He H, Ma Y, Xu J, Chen G, Sun Y and
Xiong X: Inactivation of ribosomal protein S27-like impairs DNA
interstrand cross-link repair by destabilization of FANCD2 and
FANCI. Cell Death Dis. 11:8522020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Miao H, Ren Q, Li H, Zeng M, Chen D, Xu C,
Chen Y and Wen Z: Comprehensive analysis of the autophagy-dependent
ferroptosis-related gene FANCD2 in lung adenocarcinoma. BMC Cancer.
22:2252022. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Emam A, Wu X, Xu S, Wang L, Liu S and Wang
B: Stalled replication fork protection limits cGAS-STING and
P-body-dependent innate immune signalling. Nat Cell Biol.
24:1154–1164. 2022. View Article : Google Scholar
|
